PolyNovo (ASX:PNV) has announced that current chief operating officer Dr Anthony Kaye has resigned from his position. Dr Kaye originally came from CSL Healthcare.
The medical device company notes that Dr Kaye is now returning to CSL in a higher position, having completed and commissioned PolyNovo’s new hernia product manufacturing facility.
“Anthony joined PolyNovo at a critical time to help complete our new manufacturing facility, oversee the commissioning of new machinery and put in place a team to deliver best practice production processes and costs,” said managing director Paul Brennan.
Shares in PolyNovo (ASX:PNV) are trading 4.8 per cent lower at $1.93.
Finance News Network – Latest News